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ERK activation and cell growth require CaM kinases in MCF-7 
breast cancer cells 
John M. Schmitt ·Ellen Abell · Andrea Wagner · 
Monika A. Davare 
Abstract Previous studies on MCF-7 breast cancer cells 
have sho\vn that the G-protein coupled receptor (GPCR) 
agonist carbachol increases intracellular calciun1 levels and 
the activation of extracellular signal-regulated kinase 
(ERK). Calciu1n and cahnodulin regulate the calciu1n/cal-
modulin-dependent kinase (CaM kinase) family of proteins 
that have been proposed to regulate ERK and gene tran-
scription. Our results suggest that both estrogen (E2) and 
carbachol treatment of MCF-7 breast cancer cells trigger 
phosphorylation of ERK I /2 and the transcription factor 
Elk-1. Carbachol and estrogen triggered nearly a four- to 
sixfold increase in MCF-7 cell proliferation by 96 h, 
respectively. Carbachol-stimulated ERK activation and cell 
growth was completely blocked by the Muscarinic M3-
subtype GPCR inhibitor, 4-DAMP, and siRNA against the 
M3-subtype GPCR. Interestingly, blockade of CaM KK 
with the selective inhibitor ST0-609 prevented carbachol 
activation CaM KI, ERK, Elk-1 , and cell gro\vth. Consis-
tent with these observations, knockdown of CaM KKa and 
CaM Kly with shRNA-containing plas1nids blocked ERK 
activation by carbachol. In addition, Elk-I phosphorylation 
and luciferase activity in response to carbachol treat1nent 
was also dependent upon CaM kinases and was inhibited 
by U0126, ST0-609, and siRNA knockdown of CaM 
kinases and ERK2. Finally, blockade of either CaM KK 
(\vith ST0-609) or ERK (with U0126) activities resulted in 
the inhibition of carbachol- and estrogen-mediated cyclin 
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Dl expression and MCF-7 cell growth. Taken together, our 
results suggest that carbachol treatment of MCF-7 cells 
activates CaM KI, ERK, the transcription factor Elk-1 , 
cyclin D 1, and cell grovvth through CaM KK. 
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Abbreviations 
MAPK Mitogen-activated protein kinase 
ERK Extracellular signal-regulated kinase 
CaM Calmodulin 
AKT Protein kinase B 
EGF Epidermal growth factor 
[J-Estradiol Estrogen (E2) 
CaM kinase Calcium/calmodulin-dependent protein 
kinase 
Intr oduction 
The Extracellular Signal-Regulated Kinase (ERK) is 
ubiquitously expressed throughout the body, including 
neurons, osteoblasts, n1yocytes, epithelial, and endothelial 
cells (1- 3]. ERK activation and signaling have been shown 
to be involved in nun1erous processes like neuronal men1-
ory and development, cardiac hypertrophy, apoptosis, and 
cancer [ 11. The ERK signaling pathway is under investi-
gation in cancer cells because of its regulation of several 
transcription and translation factors, and its ability to pro-
mote cell growth and proliferation. 
Previous studies have shown that the ERK pathvvay is 
activated in the breast cancer cell line, MCF-7, by various 
stimuli including epidermal growth factor (EGF), prolactin, 
angiotensin, estrogen, and carbachol [ 4- 9). Carbachol has 
been suggested to initiate activation of the ERK signaling 
pathway through the M3-subtype of muscarinic G-protein 
coupled receptors (GPCRs) in MCF-7 cells [4]. Agonist 
binding to muscarinic GPCRs triggers the activation of 
heterotrimeric G proteins of the Gq-subtype and the release 
of intracellular calcium into the cytosol of the cell. Inter-
estingly, hormones such as ghrelin, estrogen, and epi-
nephrine n1ay also cause intracellular calci un1 levels to 1ise 
inside of certain eel Is including MCF-7 cells [7 , I 0- 13). 
Calciu1n ions have a variety of intracellular targets 
including Pyk2, PKC, CalDAG-GEFs, glycogen phos-
phorylase kinase, troponin, and calmodulin [14, 15]. Cal-
cium binding to cahnodulin creates a molecular complex 
that in turn binds and activates the calcium/calmoclulin-
dependant protein kinase family of enzymes (CaM kinases) 
[16]. The CaM kinase family of proteins includes the ser-
ine/threonine enzytnes CaM KK, CaM KII, CaM KIV, and 
CaM-KI as \Veil as their various isoforrns and splice vari-
ants. Active CaM K.K phosphorylates and activates AMP-
dependent kinase (AMPK), CaM KI, and CaM KIV as well 
as the pro-survival serine/threonine protein kinase, AKT 
[15]. The physiological roles for CaM KK proteins have 
been an area of active investigation, and CaM KK has 
recently been linked to dendritic cell survival, autophagy, 
energy hon1eostasis, and neuronal develop1nent [ I 0, 17- 20). 
Studies in neurons have den1onstrated that CaM KK and 
CaM KJ activate ERK through Ras, Raf- l, and MEK [19, 
2 1). ERK activation in neurons has been shown to regulate 
both protein synthesis as well a-; gene expression [22, 23). 
Interestingly, MCF-7 cells do not express endogenous CaM 
KIV; however, CaM KK working through CaM KI has 
been implicated in signaling pathways that promote MCF-7 
cell gro\vth and proliferation [23, 24]. It is currently 
unkno\vn \Vhether the CaM KK and CaM Kl utilize ERK 
or its substrates to control MCF-7 cell growth and 
proliferation. 
Extracellular signal-regulated kinase promotes a nu1nber 
of cellular functions such as increased gene transcription 
and protein translation, increased cell cycle progression, 
cell adhesion, blockade, or promotion of apoptosis and cell 
growth [1, 25]. ERK has several cytoplasrnic and nuclear 
targets that it utilizes to control cellular function. For 
exan1ple, ERK is able to trigger phosphorylation of the 
transcription factor CREB leading to the increased 
expression of Wnt-2 genes in neurons [19). ERK can also 
phosphorylate p90Rsk, MSKl/2, MNKl/2, c-Fos, and the 
transcription factor Elk- I, among others [26- 34). Elk- I is 
an Ets family transcription factor that dimerizes with seru1n 
response factor (SRF), binds DNA, and increases tran-
scription. Elk-1 typically binds DNA upstream of the 
transcription start site in consensus regions called serum 
response elements (SREs) [35- 39]. ERK can directly 
phosphorylate Elk-I on serine 383 to enhance SRE bind-
ing, gene transcription, and cell proliferation [5, 37]. 
Interestingly, estrogen has been shown to increase Elk-1 
phosphorylation and SRE activity via ERK in MCF-7 cells; 
however, the mechanism of ERK activation do\vnstream of 
estrogen remains unkno\vn [29]. Moreover, the ability of 
CaM kinases to specifically mediate calcium's effects on 
ERK and Elk- I do\vnstrea1n of estrogen or GPCR agonists 
such as carbachol is an area of interest. 
Several genes have been den1onstrated to be activated by 
honnones and agonists in breast cancer cells. For exa1nple, 
estrogen has been shown to increase expression of the early 
growth response-] (Egr-1) and c-fos genes through ERK 
and Elk-I in MCF-7 cells f 5, 6, 401. In addition, recent data 
suggests that prolactin treatment of MCF-7 cells increased 
synthesis of the transcription factor, activating protein 1 
(AP-1) [9]. The cell cycle regulatory protein, cyclin Dl , 
has also been proposed to be over-expressed in nearly SOo/o 
of all breast cancer cases [41- 43]. Interestingly, a recent 
study by Rodriquez-Mora et al. suggested that CaM kinases 
may play a role in regulating cyclin DI expression in MCF-
7 cells [24]. The precise role of ERK and Elk- I down-
stream of CaM kinases in cyclin DI expression was not 
exa1nined. Cyclin D 1 is also regulated by several hormones 
including estrogen; however, the CaM kinase- and ERK-
dependent promotion of cyclin DI expression have not 
been investigated in MCF-7 cells. Furthennore, we are 
currently una'A1are of a 1nechanism by which carbachol that 
activates ERK and enhances MCF-7 cell growth, triggers 
cyclin DI expression in MCF-7 cells. Our ain1 wa<; to 
carefully evaluate the roles of CaM kinases in calcium's 
activation of ERK and Elk-I and the expression of cyclin 
DI in MCF-7 cells. We have utilized molecular biochem-
ical as well as pharmacological approaches to assess the 
ability of these molecules to act as mediators of MCF-7 cell 
growth and proliferation. 
Experimental procedures 
Materials 
4-DAMP and ST0-609 were purchased from Tocris (Ell-
isville, MO). EGTA, Carbachol, DMSO, /3-estradiol 
(Estrogen, E2), EGF, Flag (M2) antibody, Flag (M2)-con-
jugated agarose, and MTI reagent (Thiazolyl blue tetra-
zoliun1 bromide) were purchased fron1 Sigma. KN-93, 
ionornycin, and UOI26 \Vere purchased fro1n EMD Bio-
sciences (Calbiochem, Riverside, CA). Antibodies specific 
to phosphorylated and activated ERK (pERKl/2) that bind 
phosphorylated ERKI and ERK2 at residues threonine 202 
and tyrosine 204 were purchased from Cell Signaling 
(Beverly, MA). Phosphorylation-specific antibodies to 
activated Elk-1 (phospho-serine 383) and total Elk-1 were 
also purchased from Cell Signaling (Beverly, MA). Anti-
bodies to cyclin Dl and ATP-citrate lyase v,iere purchased 
from Cell Signaling (Beverly, MA). Antibodies to total 
ERK proteins (ERKl/2), the M3-subtype muscarinic 
receptor (H-210), and total CaM Kl were purchased from 
Santa Cruz Biotechnology Inc (Santa Cruz, CA). Mono-
clonal antibodies to phosphorylated and activated CaM KT 
(pCaM KT, threonine 177) were generated fron1 irnn1unized 
mice and a gift of the Soderling laboratory at OHSU 
(Portland, OR). HRP-conjugated secondary antibodies 
\Vere purchased fron1 Santa Cruz Biotechnology (Santa 
Cruz, CA). The siRNA to the M3 receptor and control 
siRNA-a were purchased fro1n Santa Cruz Biotechnology 
(Santa Cruz, CA). Enhanced luminal reagent was pur-
chased from Pierce Biotechnology (Rockford, JL). The 
scrambled control and p42 ERK siRNAs were purchased 
from Cell Signaling (Beverly, MA). Lipofectamine 2000 
\Vas purchased from lnvitrogen (Carlsbad, CA). The 
luciferase assay kit was purchased from Stratagene (La 
Jolla, CA). 
Cell culture and treatments 
The MCF-7 breast adenocarcino1na cell line was purchased 
fron1 ATCC and cultured in Eagle' s Minin1al Essential 
niedium (EMEM) plus l 0% fetal bovine serun1, penicillin/ 
strepton1ycin, Earle's BSS and L-glutan1ine at 37°C in 5% 
C02. Prior to cell stimulations, MCF-7 cells \.Vere serum 
starved overnight in E.MEM at 37°C in 5% C02 for western 
blotting. MCF-7 cells were pretreated with the inhibitors 
KN-93 (5 µM), U0126 (10 µM), 4-DAMP (2 µM), ST0-
609 (5 µM), or 2 mM EGT A for 30 min prior to treatment. 
Where indicated, cells were stimulated with ionomycin 
(1 µM), EGF (300 ng/ml), E2 (10 nM), H20 2 (10 nM), and 
carbachol (10 µM) for the indicated times. Treated and 
stimulated MCF-7 cells were analyzed by either SDS-
PAGE, western blotting, luciferase activity, or the MTT 
assay as indicated. 
Western blotting 
Immediately after MCF-7 cell stimulation the EMEM was 
aspirated and equivalent amounts of ice-cold lysis buffer 
(IOo/o glycerol, I% NP40, 50 1nM Tris-HCI pH 7.4, 
200 mM NaCl, 2 1nM MgCl2) plus freshly added inhibitors 
(I niM PMSF, 2 µg/1111 aprotinin, 1 ~tg/n1l leupeptin, 1 111M 
sodiu1n orthovanadate) were added to each plate of cells. 
On ice, plates were scraped and cellular proteins placed in 
ice-cold microcentrifuge tubes. Whole cell lysates were 
briefly spun at 8 K for 5 min at 4°C to pellet the cyto-
skeleton and nucleotides. Supernatants from each 
experilnental treatment were then quantified by the Brad-
ford protein assay on a 96-well plate along \Vith bovine 
serum albu1nin standards. Protein standards and sample 
concentrations were read by a Bio-Rad 680 micro-plate 
reader. Equivalent amounts of MCF-7 cell extracts were 
run on PAGE-gels, transferred to PVDF 1ne1nbranes, and 
exatnined by western blotting. Membranes \Vere probed 
using the indicated antibodies, incubated \vith luminol, 
scanned and densirized using a n1olecular in1aging systen1 
(Kodak 1n1age Station 2000R), and evaluated for signifi-
cant differences an1ong treat1nents. Band densities were 
nonnalized to untreated controls and then to the loading 
control and presented as fold phosphorylation as indicated. 
siRNA/shRNA transfections 
Fifty to sixty percent confluent cells were transfected with 
either the scrambled control siRNAs or siRNAs directed to 
either the M3 receptor (Santa Cruz Biotechnology) or p42 
ERK (Cell Signaling Technology), according to the man-
ufacturer' s guidelines (Cell Signaling Technology). Each 
plate received the same a1nount of siRNA (20 mM), fol-
lowing transfection cells were allowed to recover in co1n-
plete media for 24 h. Cells were also co-transfected with 
Flag-ERK2 along \Vith one of the following; siM3, shCaM 
KKa, shCaM Kly, shCaM KN, constitutively active (ca) 
CaM KK, caCaM KT, caCaM KK/KT, 5Gal4E I B-lucifer-
ase, Gal4-Elk- l, control siRNA-a, or pcDNA3 as indicated 
using Lipofectamine 2000 for 6 h. These plasn1ids were a 
gift of the Soderling laboratory at OHSU (Portland, OR) 
and have been described previously [19- 2 1, 44]. Each plate 
received the same total amount of plasmid (5 ~tg), fol-
lowing transfection cells were allowed to recover in com-
plete media for 24 h. Cells were then serum starved 
overnight, treated as indicated and lysed in ice-cold lysis 
buffer. Cellular lysates were examined by western blot, 
immunoprecipitated, and then examined by western blot or 
luciferase activity as indicated. 
Immunoprecipitations and western blotting 
MCF-7 cells were transfected, sti1nulated, lysed, and 
equivalent protein amounts were used for either imn1uno-
precipitation or for SDS-PAGE and blotted onto PVDF 
me1nbranes and examined by western blotting as previ-
ously described [2 1 ]. For transfected lysates, ~ 500 ~tg of 
protein was precipitated overnight at 4°C using the indi-
cated antibody. Precipitates were washed 2X in ice-cold 
lysis buffer, run on SDS-PAGE gels, and analyzed by 
western blotting. Membranes were probed using the indi-
cated antibodies, scanned, densitized using a molecular 
imaging syste1n (Kodak Image Station 2000R), and eval-
uated for significant differences among treatinents. Band 
densities were normalized to untreated controls and then to 
the loading control and presented as fold phosphorylation 
or expression as indicated. 
Luciferase assay 
MCF-7 cells were transfected with 5Ga14ElB-luciferase, 
Gal4-Elk-1 , and pretreated with inhibitors or co-transfected 
\vith pcDNA3 or shRNAs as indicated. Stin1ulated cells 
were lysed nsing luciferase assay lysis buffer and analyzed 
according to the manufacturer's protocol (Stratagene, La 
Jolla, CA). T1nmediately follovving cell lysis, equivalent 
protein amounts were assayed for luciferase activity by 
incubation with luciferase substrate every 8 s for I min. 
The average light units per treatment \Vere calculated and 
normalized to untreated controls and presented as fold 
luciferase activity as indicated. 
Cell growth assay 
In order to measure cell gro\vth and proliferation, MCF-7 
cells \Vere seeded at low-density ("' 500 cells/well) on 96-
well plates with complete EMEM media for 24 h to allo\v 
then1 to adhere. MCF-7 cells \Vere then serum starved for 
24 h and then pretreated with appropriate inhibitors for 
30 1nin. Carbachol (10 µM), E2, EGF, or controls co1n-
pounds were then added to each well as indicated for up to 
96 h. Next, 20 ~LI of MTT reagent (Thiazolyl blue tetra-
zoliu1n bro1nide) was added and incubated for 3 h at 37°C. 
The MTT-treated cells were carefully homogenized by the 
addition of SDS-containing detergent, and the plate was 
read using a microplate reader (Bio-Rad Model 680) with 
the 595 and 655 nm filters as previously described [451. 
Absorbance values were normalized to untreated controls 
and presented as fold cell growth as indicated. 
Statistics 
In order to evaluate \Vhether significant differences existed 
between experimental treatments, we performed a Student t 
test on the data with significance levels set at 0.05. Sig-
nificant values (P values) are indicated in the figures as 
either a single asterisk where P < 0.05 or a double asterisk 
where P < 0.01. 
Results 
Carbachol, estrogen, and EGF have previously been shov.1n 
to increase ERKI /2 phosphorylation and activation in 
MCF-7 cells [4, 71. We investigated the ability of these 
agonists to trigger ERKJ/2 phosphorylation and activation 
within 5 min of stimulation in our MCF-7 model syste1n. 
10 µM carbachol treatment of MCF-7 cells triggered ERK 
1/2 phosphorylation (pERKl/2) \vithin 5 min as measured 
by western blotting for the activated form of ERKI/2 
(Fig. l a). Similarly, treatment of cells with either /J-estra-
diol (E2) or EGF promoted ERK1/2 phosphorylation 
within 5 1nin, whereas neither DMSO nor H20 2 activated 
ERKl/2. Carbachol and E2 have been proposed to increase 
intracellular calcium concentrations as a means to activate 
ERK I /2 (ERK). Ionomycin is an ionophore capable of 
stin1ulating increases in intracellular calcin1n and is a 
useful mi1nic to study intracellular calciu1n signaling 
pathways. Tnterestingly, treat1nent of MCF-7 cells v.1ith 
iono1nycin, potently stimulated ERK phosphorylation 
within 5 min (Fig. l b) . In order to evaluate the physio-
logical effects of these agonists on MCF-7 gro\vth and 
proliferation cells were stimulated as indicated and ana-
lyzed after 96 h. E2 and EGF triggered a six- and sevenfold 
increase in cell growth by 96 h, respectively. Moreover, 
carbachol stiinulated a fourfold increase in cell growth, 
v.1hereas DMSO and a sub-lethal dose of H20 2 had no 
effect on cell growth at this titne point (Fig. l e). Interest-
ingly, pre-treatment with EGTA, a calcium chelator, 
completely blocked carbachol activation of ERK (Fig. l d). 
Taken together, the above data suggest that agonists that 
elevate intracellular calcium are capable of activating ERK 
and pro1noting MCF-7 cell growth. 
MCF-7 cells express the M3-subtype of muscarinic 
GPCRs that couple to elevation of intracellular calcium 
following carbachol sti1nulation [4]. Jn order to examine 
the role of M3 receptors in ERK activation, we pre-treated 
MCF-7 cells with 4-DAMP, a selective M3 receptor 
antagonist that completely blocked carbachol's activation 
of ERK (Fig. 2a). In order to ensure the specificity of 
4-DAMP in our system, MCF-7 cells were pre-treated with 
either 4-DAMP followed by stimulation with EGF. ERK 
activation by EGF was not effected by pre-treatment with 
4-DAMP (Fig. 2b). In addition to the pharmacological 
approach of inhibiting the M3 receptor, \Ve also employed 
siRNA transfection of MCF-7 cells as a means to further 
evaluate the requirement of the M3-subtype GPCR in ERK 
activation. Transfection of MCF-7 cells with siRNA 
directed against the M3 receptor knocked down its 
expression by 37% as co1npared to control transfected cells 
(Fig. 2c). The knockdown of the M3 receptor was specific, 
because total ERK levels were unchanged in either trans-
fection groups (Fig. 2c). Consistent \vith the previous 
results, co-transfection of cells with siRNA directed at the 
M3 GPCR along with Flag-ERK2 significantly inhibited 
carbachol activation of ERK2 as compared to control cells 
transfected with scrambled siRNA (Fig. 2d). Consistent 
with its effects on ERK activation, inhibition of the M3 
receptor using 4-DAMP also blocked carbachol's stimu-
lation of cell growth (Fig. 2e). 
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Fig. l Agonist activation of ERK and f\1CF-7 cell growth. a ERK 
activation by carbachol, estrogen, and EGF. Serun1-starved MCF-7 
cells \Vere sti1nulated with carbachol (I 0 µl\1), P·estradiol (E2, 
!OnM), EGF (300 ng/ml), H20 2 (!OnM), or DMSO for 5 1nin as 
described in "Experi1nental procedures" section. Untreated control 
cells arc indicated by the letter "C". Cell lysates were prepared as 
indicated in "Experi1ncntal procedures" section. Endogenous ERK 
activation was measured by v1estern blotting for phosphorylated 
ERKl/ERK2, p44 and p42, respectively (pERKl/2). The lower panel 
is a \Vcstcrn blot of ERK l/2, de1nonstrating equal loading of ERK 
used for pERKl/2 assays. b Ionomycin activates ERK in IvlCF-7 
cells. MCF-7 cells received no treatment or were sti1nulated with 
iono1nycin (1 µM) for 5 rnin as described in "Experi111ental 
Several cellular enzymes have been shown to be acti-
vated by increases in calcium ion concentration and to 
participate in ERK activation including the calcium/cal-
modulin-dependent protein kinase (CaM kinase) group of 
molecules. In order to investigate whether CaM kinases 
\Vere involved in carbacho1's activation of ERK, cells were 
pretreated with the selective CaM kinase family inhibitor 
compound, KN-93. Inhibition of the CaM kinase family of 
proteins with KN-93 blocked ERK activation (Fig. 3a). 
ERK activation was also dependent upon its in1mediate 
upstream activator MEK, as ERK phosphorylation by 
carbachol \vas con1pletely blocked by the MEK inhibitor, 
UO 126 (Fig. 3a). In order to fu11her exan1ine the role of 
CaM kinases downstream of calcium activation of ERK, 
MCF-7 cells were pre-treated with KN-93 and then stim-
ulated with ionomycin. As can be seen in Fig. 3b, inhibi-
tion of CaM kinases blocked ionomycin-stimulated 
activation of ERK. In order to ensure that KN-93 \Vas 
selectively inhibiting calcium/CaM kinase-dependent pro-
cesses, cells were pretreated with KN-93 and then exposed 
to EGF. KN-93 had no effect on EGF-triggered calcium-
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procedures" section. Endogenous ERK activation was rneasured by 
\vesten1 blotting as in panel A. c Carbachol triggers MCF-7 ce.11 
growth. MCF-7 cells were senun starved and stin1ulated for 96 h \vith 
the indicated agonists as described in "ExperiJnental procedures" 
section. Data are presented as cell gro,vth over control (N = 5). 
d ERK activation by carbachol is calciu111 dependent. MCF-7 cells 
received no pretreatment or 1.vere pretreated with EGTA (2.5 n1JvJ) 
and then stimulated with carbachol (10 µM) for 5 min. Endogenous 
ERK activation \Vas measured by \vestern blotti.ng as in panel A and 
the bands were densitized, nom1alizcd to ERK 1/2, and quantitated. 
Data are presented as fold ERKl/2 phosphorylation over control 
(N = 4 ± SE, * P < 0.05) 
independent activation of ERK (Fig. 3c). Estrogen and 
ionomycin are capable of increasing intracellular calcium 
concentration and ERK activation. In order to determine if 
these agonists activate ERK through its common activator 
MEK, cells were exposed to the MEK inhibitor UO 126. 
Blockade of MEK by UOI26 completely abolished ERK 
activation by iono1nycin (Fig. 3d) and estrogen (Fig. 3e). 
The above data suggests that calcium-elevating agonists 
utilize the enzyn1e MEK and the CaM kinase fa1ni ly of 
proteins to activate ERK. 
CaM KK and CaM KT have been suggested to promote 
MCF-7 cell growth and proliferation [24]. In order to 
determine if CaM KK n1ediates ERK activation in our 
system, MCF-7 cells \Vere pretreated with the speci fie CaM 
KK inhibitory co1npound, ST0-609 [23, 461. Interestingly, 
both carbachol- and estrogen-stimulated activation of ERK 
were significantly blocked by inhibiting CaM KK with 
ST0-609 (Fig. 4a, b). In order to ensure that the ST0-609-
mediated inhibition of ERK was due to specifically sup-
pressing CaM KK, we stimulated MCF-7 cells \Vi th EGF in 
the presence of the inhibitor. CaM KK inhibition did not 
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Fig. 2 Carbachol sti!nulation of ERK and MCF-7 cell gro\vth 
requires the M3-subtype of GPCRs. a Carbachol activation of ERK is 
blocked by the 113 -subtype receptor inhibitor, 4-DAMP. MCF-7 cells 
received no pretreatment or were pretreated with 4-DAMP (2 ~tM) 
and then stimulated with carbachol (10 ~~M) for 5 rnin. Endogenous 
ERK activation was nieasurcd by western blotting for phosphory-
lated-ERK l/ERK2 (pERKl/2). P hospho-ERK bands \Vere densitized, 
normali:£ed to ERKl/2, and quantitated. Data are presented as fold 
ERKJ/2 phosphorylation over control (1V = 6 ± SE., *~' P < 0.01). 
b 4-DAMP docs not effect EGF activation of ERKl/2. MCF-7 cells 
received no pretreatlnent or were pretreated with 4-DAMP (2 ~111) 
and then stin1ulated with EGF for 5 nlin. Endogenous ERK activation 
\vas 1ueasured by western blotting and analyzed as in panel "A" 
(/1l = 6 ± SE). c siRNA to the M3-subtype of GPCRs reduces its 
expression. MCF-7 cells \Vere transfected wi th either scran1blcd 
effect EGF's activation of ERK (Fig. 4c) suggesting that 
ST0-609 had no effect on a classical n1echanism of ERK 
activation or ERK itself. CaM KK has several direct sub-
strates including the phosphorylation of CaM KI at threo-
nine 177. Jn order to confirm that the effect of ST0-609 on 
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siRNA or si.RNA against the M3 receptor as described in "Experi-
n1enta\ procedures" section. Endogenous M3 expression \Vas niea-
sured by western blotting and the bands \Vere densitized, normalized 
to ERKJ/2, and quanlilated. Data are presented as fold l\13 expression 
over ERKJ/2 (N = 6 ± SE). d The M3 receptor mediates carbachol 
activation of ERK. lv!CF-7 cells \Vere co-transfected wi th F lag-ERK2 
along with the control siRNA or the siRNA against the M3 receptor as 
indicated in ".Experi.Jnental procedures" section. MCF-7 cells were 
then sti1nulated with carbachoJ (LO µM) for 5 min and Flag-ERK2 
phospllorylation was analyzed as indicated in .. Experin1ental proce-
dures" section (N = 6 ± SE). e lv!CF-7 cell growth utilizes the l\13 
receptor. MCF-7 cells received no pretreatn1ent or \Vere pretreated 
with 4-DANIP (2 µM) and then stimulated with carbachol (10 ~1M) 
for 96 h. Data are presen ted as cell growth over control (1V = 4) 
ERK was due to block of CaM KK activity, we exa111ined 
the ability of ST0-609 to block CaM KK phosphorylation 
and activation of CaM KI. Carbachol and ionomycin both 
activated CaM KK and its phosphorylation of CaM Kl in 
our systen1 and ST0-609 strongly blocked activation of 
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Fig. 3 Agonist activation of ERK depends on CaM kinases and 
MEK. a U0126 and KN-93 block carbachol activation of ERK. MCF-
7 cells received no pretreatn1ent or \Vere pretreated with either UOl 26 
(I 0 ~IM) or KN-93 (5 ~LlYI) and then stin1ulated \vi th carbachol 
(10 µJYI) for 5 min. Endogenous ERK activation was measured by 
western blot.ting for phosphorylated ERKl/ERK2 (pERKl/2). Phos-
pho-ERK bands were dcnsitized, norn1alizcd to ERKl/2, and 
quantitated. Data are presented as fold ERK 1/2 phosphorylation over 
control (N = 4 ± SE). b KN-93 blocks ionomycin activation of 
ERK. tvfCF-7 cells \Vere pretreated identically to panel A and then 
stimulated \Vith ionoo1ycin (1 µM) for 5 1nin. Endogenous ERK 
activation was measured and analyzed as in panel A (1\/ = 4 ± SE). 
CaM KI by CaM KK (Fig. 4d, e). This data suggest that 
CaM KK mediates ERK activation downstrea1n of carba-
chol and estrogen stimulation of MCF-7 cells. 
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c KN-93 does not block EGF-stimu.lated phosphorylation of ERK. 
t-.1CF-7 ceUs were pretreated identically to panel A, then stimulated 
\Vith EGF (300 ng/n1I) for 5 rnin and ERK was analyzed as in panel 
A. Endogenous ERK activation \vas n1easured and analyzed as in 
panel A (N = 4 ± SE). d U0126 blocks ionomycin activation of 
ERK. MCF-7 cells '"ere pretreated identically to panel A and then 
sti rnulatcd \Vith ionon1ycin (1 fLM) for 5 n1in. Endogenous ERK 
activation was n1easw·ed and analyzed as in panel A (N = 4 ± SE). 
c Estrogen activation of ERK requires MEK. MCF-7 cells \vere 
pretreated identically to panel A and then stilnulated with /J-estradiol 
("E2" , 10 nM) for 5 min. Endogenous ERK activation \Vas 1neasured 
and analyzed as in panel A (N = 6 ± SE) 
Recent data suggest that the alpha isoform of CaM KK 
and the ga1n1na isoform of CaM KI tnediate ERK activa-
tion in neurons [ 19). In addition to the phannacological 
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were densitized, nonnalized to ERKl/2, and quantitatcd. Data are 
presented as fold ERK 1/2 phosphorylation over control 
(1V = 6 ± SE). b Estrogen act.ivation of ERK requires CaM KK. 
MCF-7 cells were pretreated identically to panel A and then 
stin1ulatcd with P-estradiol ("E2", 10 nM) for 5 n1in. Endogenous 
ERK activation was 1neasured and analyzed as in panel A 
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KK. MCF-7 cells were pretreated identically to panel A, then 
stimulated with EGF (300 ng/1nl) for 5 1nin and ERK \Vas analyzed as 
in panel A (N = 4 ± SE). d Carbachol activates CaM KT via CaM 
KK. MCF-7 cells were pretreated identically to panel A and then 
stimulated with carbachol (10 !lM) for 5 min. Endogenous CaM 
kinase I activation was measured by \11es1ern blotting for phosphor-
ylated CaM kinase T (pCaM KI). Phospho-Cal\1 KJ bands were 
densitized, norn1alized to CaM KT, and quantitated. Data are 
presented as fold Ca!vl Kl phosphorylation over control 
(1V = 8 ± SE). e lonomycin stimulates CaM Kl phosphorylation. 
MCF-7 cells \Vere pretreated identically to panel A and then 
stimulated \vith iono1nycin (1 !lM) for 5 min. Endogenous Cal\1 Kl 
activation \vas 1neasured and analyzed as in panel D (1V = 4 ± SE) 
approach to inhibiting CaM KK and CaM Kl in our cells, 
we also transfected short-hairpin RNA (shRNA) directed 
against either CaM KKa, CaM Kly, or CaM KlV and 
examined ERK activation. Transfection of cells with the 
control pcDNA3 had no effect on co-transfected Flag-CaM 
KKa, Flag-CaM Kly, or Flag-CaM KIV (Fig. Sa). In con-
trast, transfection of cells \Vith shCaM KKa, sbCaM Kiy, or 
sbCaM KIV significantly blocked each of their expression, 
respectively. The shRNAs nor pcDNA3 did not alter the 
expression of /3-tubnlin, Flag-ERK2, or Flag-CaM KT these 
proteins also functioned as loading controls (Fig. Sa). In 
order to detennine the role of CaM KKo: on ERK activa-
tion, MCF-7 cells were co-transfected with either pcDNA3 
or shCaM K.Ko: along \vith Flag-ERK2 and then stimulated 
with carbachol. Carbachol treatment of control cells trig-
gered a twofold increase in ERK activation an effect that 
\Vas significantly blocked by expression of shCaM KK.a 
(Fig. Sb). In order to evaluate the role of the CaM Kly in 
calcium-mediated ERK activation, cells were co-transfec-
ted with either pcDNA3 or shCaM Kly along \Vitb Flag-
ERK2 and then stiinulated with carbachol. As can be seen 
in Fig. Sc, carbachol increased ERK activation \Vas com-
pletely inhibited by the presence of the shCaM Kiy. These 
data suggest that CaM KK and CaM KI are necessary for 
ERK activation. In order to confirm the specificity of the 
CaM kinases involved in ERK activation, we also exam-
ined whether shCaM KTV effected ERK activation. Inhi-
bition of CaM KTV did not block ERK phosphorylation 
downstrean1 of carbachol stin1ulation (Fig. Sd). Jn order to 
investigate the ability of CaM KK and CaM Kl to stin1ulate 
ERK activation independent of agonist stin1ulation, cells 
\vere co-transfected with either pcDNA3 or constitutively 
active (ca) CaM KK, caCaM Kl, or both caCaM KK/Kl 
along ~1ith Flag-ERK2. Both caCaM KK and caCaM Kl 
were sufficient to trigger ERK activation in our system 
independent of agonist stimulation (Fig. Se). Taken toge-
ther, the above data suggest that CaM KK and CaM KI are 
both necessary and sufficient for ERK activation in MCF-7 
cells. 
In order to determine if carbachol-mediated ERK acti-
vation controlled do\vnstrea1n substrates and physiological 
targets \Ve evaluated the phosphorylation state of the 
transcription factor Elk- l on serine 383. Elk-1 has been 
suggested to activate transcription as a downstream sub-
strate of ERK and has been in1plicated in cell growth and 
proliferation [29, 47-49). We initially used a pharmaco-
logic approach to evaluate the role of CaM kinases and 
ERK in Elk-1 phosphorylation. Sin1ilar to ERK regulation, 
Elk- I v.1as phosphorylated in response to carbachol treat-
ment of MCF-7 cells in a MEK/ERK- and CaM KK-
dependent manner as its phosphorylation was inhibited by 
U0126, KN-93 , and ST0-609, respectively (Fig. 6a, b). In 
order to assess the ability of carbachol to stin1ulate Elkl-
mediated gene transcr1pt1on, cells were transfected with 
Gal4-Elk-l and the Ga14 laciferase reporter gene plasrnids 
in the presence or absence of U0126 and ST0-609. Car-
bachol-stimulated Elk-1 luciferase activity was signifi-
cantly blocked by inhibiting either ERK or CaM KK 
(Fig. 6c). In order to further evaluate whether CaM KK or 
CaM Kl were upstreatn of Elk-1 in our system, cells were 
transfected as in panel c along with either pcDNA, shCaM 
KK-'.X, or shCaM Kly and then stimulated with carbachol. 
Carbachol-stimulated Elk- I luciferase activitv \vas blocked 
-
by either shCaM KKa or shCaM Kly (Fig. 6d). The rela-
tionship bet\.veen ERK phosphorylation of Elk- I was fur-
ther investigated in cells transfected with either control 
siRNA or siERK2. Transfection of MCF-7 cells with 
siERK2 significantly knocked down its expression relative 
to control-transfected cells (Fig. 6e). As a control for 
specificity, neither the control siRNA nor siRNA to ERK2 
had an effect on ATP-citrate lyase expression (Fig. 6e). 
Furthermore, carbachol stimulation of control siRNA 
transfected cells triggered phosphorylation of Elk-1, an 
effect that \Vas completely blocked by expression of 
siERK2 transfected cells (Fig. 6f). This data suggest that in 
MCF-7 cells CaM KK, CaM KI, and ERK2 are required for 
phosphorylation and activation of Elk-I following carba-
chol sti1nulation. 
Previous research has suggested that calcium and CaM 
kinases are capable of regulating the expression of cyclin 
DJ in MCF-7 cells [24). Cyclin Dl is a critical n10Jecule 
that pron1otes progression of cells through the cell cycle 
leading to their growth and proliferation. Based on this 
information, \Ve investigated the ability of carbachol to 
induce cyclin Dl expression through CaM KK and ERK in 
our system. Carbachol was capable of increasing cyclin DJ 
expression over twofold within 4 h of cell stimulation, an 
effect that was sustained for at least 24 h (Fig. 7a). In 
contrast, pretreatment of cells with UOI26 (UO) to inhibit 
MEK and ERK attenuated the ability of carbachol to 
iI1crease cyclin Dl expression at all time points exarnined 
(Fig. 7a, Jniddle panels and graph). Similarly, inhibition of 
CaM KK with ST0-609 (S) also blocked carbachol's 
induction of cyclin D l (Fig. 7a, lower panels and graph). 
We also sought to examine whether CaM KK and ERK 
1nay be participating in estrogen ' s induction of cyclin Dl 
expression. Consistent with the previous work [SO], estro-
gen induced cyclin DI expression by 2 h and was n1ain-
tained for at least 6 h (Fig. 7b). Inhibition of either ERK 
with UOJ26 or CaM KK with ST0-609 substantially 
reduced the ability of estrogen to induce cyclin DI 
expression (Fig. 7b). Consistent v.1ith these results, block-
ade of either CaM KK or ERK activities resulted in the 
inhibition of carbachol-stimulated cell growth (Fig. 7c). In 
order to control for the specificity of ST0-609 in our cell 
growth assay, MCF-7 cells were also sti1nulated with EGF 
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Fig. 5 Carbachol activation of ERK requires CaM KK and CaM Kl 
a shRNA to Cal\1f KKa, CaM KTy, or CaM KTV inhibit their own 
expression. Cos-7 cells were transfected with either pcDNA3 or 
shRNA plasrnids directed against either CaM K.Ko:, CaM KI7, or CaM 
KIV and Flag-CaM KKix, Flag-CaM Kiy, or Flag-CaM KIV as 
described in ;<Experin1ental procedures" section. Flag expression \vas 
measured by v1estern blouing, and the bottom panels are western blots 
of P-tubulin, Flag-ERK2, or Flag-CaM Kly, demonstrating equal 
loading of proteins used for western blotting assays. b ERK activation 
requires CaM KKa. MCF-7 cells were co-transfected with Flag-ERK2 
along with the control vector pcDNA3 or shRNA to CaM KKo:. JYJCF-
7 cells \Vere stimulated \vilh carbachol ( I 0 riM) for S min and Flag-
ERK2 phosphorylation was densitized, norrnalized to Flag-ERK.2, 
quantitated and analyzed as indicated in "Expcri111cntal procedures" 
in the presence or absence of the CaM KK inhibitor. As can 
be seen in Fig. 7d, ST0-609 did not block EGF-stimulated 
cell gro\vth. Taken together, our results suggest that both 
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section (N = 6 ± SE). c Carbachol activation of ERK requires CaM 
KTy. MCF-7 cells \Vere co-transfected with Flag-ERK2 along with the 
control vector pcDNA3 or shRNA to CaM Kly. MCF-7 cells were 
stitnulated with carbachol ( 10 ~tlvl) for 5 1nin and Flag-ERK2 
phosphorylation was analyzed as in panel B (N = 6 ± SE). d 
Carbachol activation of ERK is CaM KIV independent. MCF-7 cells 
were co-transfected \vith Flag-ERK2 along wi th the control vector 
pcDNA3 or shRNA to CaM KTV (sh KIV). MCF-7 cells were 
stitnulated with carbachol ( 10 ~tlvl) for 5 1nin and Flag-ERK2 
phosphorylation \Vas analyzed as in panel B (N = 4 ± SE). e CalYJ 
KK and CaM KT are suflicient to activate ERK. MCF-7 cells \Vere co-
transfected with Flag-ERK2 along with the control vector pcDNA3, 
caCaM KK, caCaM KI, or CaM KK and CaM Kl. Flag-ERK2 
phosphorylation \Vas analyzed as in panel B (1V = 4 ± SE) 
carbachol and estrogen treat1nent of MCF-7 cells induce 
the expression of cyclin D l and promotes cell growth in a 
CaM KK and ERK-dependent 1nanner. 
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Fig. 6 Carbachol phosphorylation of the transcription factor Elk- 1 is 
ERK-, CaNl KK-, and CalVI Kl-dependent. a Carbachol-sti1nulated 
phosphorylation ofElk-1 is blocked by U0126 and KN-93. MCF-7 cells 
received no pretreatrnent or were pretreated with either UOl 26 (l 0 µM) 
or KN-93 (5 µM) and then stin1ulated \Vith carbachol (10 ~1~1) for 
5 niin. Endogenous Elk-I phosphorylation (serine 383) "''as nieasured 
by western blotting (pElk-1). Phospho-Elk.-1 bands \vere densitized, 
nonnalized to total Elk-1, and quantitated. Data are presented as fold 
Elk-1 phosphorylation over control (N = 4 ± SE). b Carbachol-
stin1ulated phosphorylation of Elk-I is inhibited by ST0-609. Iv!CF-7 
cells received no pretreatment or \\lere pretreated \vi th ST0-609 (5 iit-1) 
and then sti1nulat.ed with carbachol (10 µM) for 5 ruin. Endogenous 
E.lk-1 phosphorylation (serine 383) \Vas nieasured and analyzed as in 
panel A. Data a.re presented as fold Elk- 1 phosphorylation over contTol 
(N = 6 ± SE). c Carbachol stimulates Elk. transcriptional activity via 
ERK and CaM KK. MCF-7 cells were transfected with a Gal4-
luciferase reporter and a Gal4-Elkl fusion protein and lucifcrase 
activity \vas measured as described in "Experi111ental procedures" 
section. MCF-7 cells received no pretreatment or were pretreated with 
U0126 (J 0 µM) or ST0-609 (5 µ1v1) and then stimulated with carbachol 
(F) 
(B) 
~ . 
10 
If) ~~ 
"' ..0 3 
~ 
<I) 
> 2.6 
0 
'O 1 
;§ 1.5 
~ 
... ' 
...:: 
- OS w 
0. 0 
(D) 
i?:' 3 
:~ 
-~ 2 
<I) 
~1 
:E 0 
:> 
...J 
c c 
ST0-609 
Carbachol 
l - ·- - j -pElk-1 
:;...__--==;;;;;...._,.;;;: 
-------- -Elk-1 
•• T 
c ST0-609 
Carbachol 
~-
• 
T 
• 
I I 
c shKKa shKly 
Carb. 
Carbachol 
Carb. 
siControl siERK2 
- -
- pElk-1 
-- ----
- Elk-1 
~ 3 
1Jl 1l 25 
~ 
~ 2 
'O 1.5 
.E 
~
... ' 
...:: 
u.I 0.5 
0. 
•• 
0 ...._.__..._,_..,C::,-a-r~b-. .--~..__,.....,Carb. 
siControl siERK2 
( I 0 µM) for 5 n1in. Luciferase activ ity \vas quantitated and norn1alized 
to untreated controls (N = 6 + SE). d Elk trm1sc1iptional activity 
requires CaM KK~ and Calvi Kly. MCF-7 cells were transfected with a 
Gal4-luciferase reporter, Gal4-Elkl fusion protein and pcDNA or 
sh RNA to ei ther Ca1vl KKo: or CaM KTy as indicated. ~1CF-7 cells were 
then stin1ulated with carbachol (I 0 ~tl\il) for 5 min and luciferase 
activity was measured as in panel C (N = 5 ± SE). c siRNA against 
ERK2 knocks do\vn its expression. MCF-7 cells were transfected \vith 
either scran1bled s.iRNA or siRNA con1plernentary to ERK2 as 
described in " Experimental procedw·es" section. Endogenous ERK2 
expression "''as measured by western blotting, and the bands were 
densitized, normalized to ATP-Citrate Lyase, and quantitated. Data are 
presented as fold ERK2 expression over ATP-Citrate Lyase 
(N = 9 ± SE). f Ca.rbachol-stin1ulated Elk-I phosphorylation requires 
ERK. MCF-7 cells \Vere transfected with control siRNA or the siRNA 
against ERK2 as in panel E. MCF-7 cells were then stitnulated \Vitb 
carbachol (10 ~1M) for 5 rnin and Elk- 1 phosphorylation was 111easured 
by weste111 blotting (pElk-1 ). Phospho-Elk- 1 bands were densitized, 
nonnalized to total Elk.-1, and quantitated. Data are presented as fold 
Elk-1 phosphorylation over control (N = 6 ± SE) 
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Fig. 7 Carbachol and estrogen-stunulated cyclin D l expression and 
cell grov.rth requires CaM KK and ERK. a U0126 and ST0-609 block 
carbachol-stimulated cyclin DI expression. MCF-7 cells received no 
pretreatment (top panels) or were pretreated with either UO 126 
(10 µM; 1niddle panels) or ST0-609 (5 µM; botto111 panels) and then 
stirnulated \vi th carbachol (I 0 µM) for the indicated ti rnes and in the 
presence or absence of inhibitors. Endogenous cyclin DI expression 
(cyclin Dl) was measured by western blott.ing. Western blotting of 
corresponding cellular extracts for ERKl/2 serves as loading controls. 
Cyclin DI bands \Vere densitizcd, nonnalizcd to total ERKl/2, and 
quantitated. Data are presented as fold cycJjn DI expression over 
untreated control. b Estrogen triggers cyclin DI expression through 
ERK and CaM KK. MCF-7 cells received no pretreat1nent or were 
pretreated with ei ther UOJ26 (10 ~t'NI) or ST0-609 (5 pNI) and then 
stin1ulated with P-estradiol (E2; I 0 nM) for the indicated ti1nes and in 
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the presence or absence of inhibitors. Endogenous cyclin D 1 
expression (cyclin Dl) \Vas 111easurcd by western blotting. Western 
blotting of corresponding cellular extracts for ERK 1/2 serves as 
loading controls. Cyclin D l bands were densitized, nonnalized to 
total ERKl/2, and quantitated. Data are presented as fold Cyclin DJ 
expression over untreated control. c MCF-7 stin1ulated cell growth is 
blocked by UOI 26 and ST0-609. MCF-7 cells received no pretreat-
ment or were pretreated with U0126 (10 ftNl) or ST0-609 (5 µM) and 
then sti.tnulated \vitb carbachol (10 µM) for 96 h. Data are presented 
as cell growth over control (N = 4 ±SE). d EGF-stirnulated MCF-7 
cell gro\vth is ST0-609 insensitive. MCF-7 cells received no 
pretreaunent or were preu·eated with ST0-609 (5 µM) and then 
stimulated witb EGF (300 ng/nl.l) for 96 h. Data are presented as cell 
growth over control (N = 4 ± SE) 
Discussion 
Understanding the basic biology and mechanisms that 
underlie cell gro\vth and proliferation are important areas 
of current cancer biology research. Calcium is an estab-
lished second n1essenger that is known to pro1note cell 
proliferation; ho,vever, the do,vnstream targets responsible 
for these effects have not been well defined. We have 
utilized both pha1111acological as well as n1olecular bio-
che1nical approaches to exan1ine the 1nechanism of carba-
chol and estrogen signaling in MCF-7 breast cancer cells. 
Results from previous studies suggest that carbachol and 
estrogen are sufficient to trigger an increase in intracellular 
calcium concentration as well as ERK activation [4 , 7, 13]. 
Here, we demonstrate that estrogen and carbachol treat-
ment of MCF-7 cells activates ERK and cell growth. 
Carbachol activation of ERK and cell growth appears to be 
mediated through a M3-subtype of muscarinic GPCR. 
Significantly, estrogen and carbachol utilize CaM KK and 
CaM Kl to trigger calcium-dependent ERK activation in 
MCF-7 cells. CaM KK and Cal\1 KI are also sufficient to 
trigger ERK activity as constitutively active versions of the 
kinases increase ERK phosphorylation. Inhibition of CaM 
KK and ERK blocked phosphorylation of the transcription 
factor Elk- l and cyclin D l expression downstream of 
carbachol signaling. CaM kinases, in particular CaM KK 
and CaM KI, have been proposed to regulate MCF-7 cell 
cycle progression perhaps through ERK [24]. Our results 
are the first to demonstrate that ERK, Elk-1, cyclin Dl, and 
cell growth are regulated by CaM KK and CaM KI in 
MCF-7 cells. 
Carbachol and estrogen have previously been shown to 
activate ERK via calcium in MCF-7 cells, consistent with 
the results presented here. A major receptor for intracel-
lular calciu1n is calmodulin and its targets the CaM kinases. 
The function of the CaM kinases has been the focus of 
numerous recent breakthroughs in the field of cell signaling 
(51). The best studied of the CaM kinases is CaM KII that 
has been established as a key participant in synaptic plas-
ticity, neuronal development such as axon attraction, and 
n1ammalian behavior (15]. Recent studies have i1nplicated 
CaM KII in regulating proliferation of n1uscle, myeloid 
leukemia, and osteosarcon1a cells (52-54]. For example, 
work by Si et al. demonstrated that CaM KITy is found in 
ntnnerous leuke1nia cell lines, activated by the bcr-abl 
oncogene, and 1nediates myeloid leukemia cell prolifera-
tion [52, 55]. CaM KII has also been suggested to crosstalk 
with Notch-l signaling and Hes-1 gene expression to 
promote proliferation of PC3 and C4-2B prostate cancer 
cells [55]. Interestingly, the expression of siRNAs to either 
the alpha, beta, or garnma isoforms of CaM KII had no 
effect on Hes-I gene expression, but C4-2B proliferation 
\Vas completely blocked by KN-93 at 72 h. The proposed 
role for CaM Kil in many cells including neurons is largely 
based upon the ubiquity of the protein and ability of the 
inhibitory compounds KN-93 and KN-62 to block CaM KII 
activity. However, it bas been recently \Vell established that 
the KN-62 and KN-93 co111pounds also inhibit CaM KI and 
CaM KIV thus complicating the originally proposed roles 
for CaM KII in cellular function [56]. 
CaM KI and CaM KN are both substrates for CaM KK 
and all three kinases have recently ga111ered significant 
attention downstream of calcium signaling [15, 46). The 
developn1ent of the selective CaM KK inhibitor, ST0-609, 
has enabled investigators to differentiate signaling path-
ways that 1nay utilize CaM KK but not CaM KII [46]. For 
exa1nple, CaM KK signaling has been implicated (using 
ST0-609) in macroautophagy, energy homeostasis, and 
hippocampal development [I 0, 17, 19, 20). These studies 
are consistent with our results demonstrating the ability of 
ST0-609 to inhibit CaM KK' s activation of CaM Kl, ERK, 
Elk- I, and MCF-7 cell proliferation. CaM KIV is a target 
of CaM KK and it is primarily a nuclear protein expressed 
in neurons, T cells, and testes [57-61]. CaM KIV has also 
been suggested to mediate activation of p53 gene expres-
sion by estrogen in MCF-7 cells. However, the prescribed 
role for CaM K.IV was based on the use of KN-93 and over 
expression of constitutively active CaM KIV (62]. The 
ability of CaM KIV to participate in calcium signaling in 
MCF-7 cells ren1ains controversial because it has been 
suggested that MCF-7 cells express little or no CaM KJV 
[24]. Our data suggest that CaM KIV does not 1nediate 
ERK activation downstrean1 of carbachol signaling. In 
contrast, CaM KJ appears to be a ubiquitously expressed 
cytosolic protein found in numerous cells including epi-
thelial, neurons, fibroblasts, HeLa, MCF-7, and osteoblasts 
(24, 63-661. 
CaM KI has recently been de1nonstrated to participate in 
the proliferation of rnouse cholangiocytes and osteoblasts 
[67, 68]. Additionally, CaM KI mediates cyclin Dl 
expression, cell cycle progression, and proliferation of 
serum-stirnulated Wl-38 fibroblasts (65]. Consistent with 
these results, we propose that CaM Kl mediates activation 
of ERK to regulate cyclin D l expression and cell prolif-
eration downstrea1n of calcium signaling in MCF-7 cells. 
CaM KK and CaM KI are capable of regulating ERK 
activity and neurite develop1nent in neuroblastoma cells 
[19, 21 , 23]. Furthermore, Wayman et al. demonstrated that 
CaM KK and CaM Kiy t1igger Ras/MEK/ERK activation, 
CREB phosphorylation, and Wnt-2 transcription as a 
1neans to pro1note hippocan1pal dendritic arbor fonnation 
[19]. Previous studies have suggested that CaM KK and 
CaM KI participate in MCF-7 cell cycle progression, 
consistent with those observations, we now propose that 
they are capable of acting through ERK and the tran-
scription factor, Elk-I. The exact mechanism for CaM KK/ 
Kl coupling to the Ras/MEK/ERK path\\1ay re1nains 
uncharacterized and is an area of active investigation. 
CaM Kl appears to have numerous substrates including 
the RacGEF, fJPix, Nu1nb protein, CREB, microtubule 
regulating kinase (MARK2), and p300 reviewed by Way-
man et al. [ LS]. CaM Kl also directly phospho1ylates the 
dynamin-related protein l (Drpl) at serine 600 in neurons 
and HeLa cells [66]. Drpl is a GTPase that associates with 
the n1itochond1i.al 1ne1nbrane and facilitates mitochondrial 
fission dov1nstrean1 of calcium and CaM KI signaling. The 
function of CaM KT-provoked mitochondrial dyna1nics 
appears to be ERK independent but highlights the growing 
role for CaM KT in processes that 1nay underlie cell growth. 
CaM KI has also been shown to be required for osteoblast 
proliferation and is highly expressed in endometrial carci-
no1nas; however, the role of ERK or Elk-I downstream of 
CaM Kl in these systems was not evaluated [63, 68]. 
Interestingly, KN-93 blocked cyclin Dl and cyclin A 
expression in the Ishikawa endometrial cancer cell line 
consistent with our observed role of CaM kinases being 
upstream of cyclin DJ [63, 69]. 
Previous research has also sho\.vn that estrogen and 
carbachol are capable of increasing gene expression and 
pro1noting cell growth and proliferation. Carbachol has 
been shown to increase ERK activation, cyclin D l, cyclin 
E, and p21 expression in quiescent NTH3T3 cells although 
the pathway downstrea1n of the M3 receptor what not 
carefully exan1ined [69). Cyclin Dl is a key regulator of 
cell cycle progression through the G 1 phase that, upon its 
induction, binds to cyclin-dependent kinases (CD Ks) 4 or 6 
[42]. The cyclin Dl/CDK complexes are then capable of 
phosphorylating substrates essential to promote cell pro-
liferation. Cyclin DI is one of the most cotnmonly over-
expressed proteins in breast cancer and is found in nearly 
SOo/o of all breast cancer cases [ 4 I, 70]. Recent work has 
demonstrated that overexpression of cyclin Dl in MCF-7 
cells increases their growth rates and may be a therapeutic 
target for anticancer drugs [71]. Our work here is the first to 
dernonstrate that M3 muscarinic receptor activation by 
carbachol activates Elk- I transcription and increases cyclin 
D 1 expression in MCF-7 cells via CaM KK and ERK. 
Cyclin D l is important for MCF-7 cell cycle progression 
and has nurnerous transcriptional inducers including AP-1, 
CREB, JAK-STATs, Ets proteins (of which Elk-1 belongs), 
and Sp-1 [72- 74). Elk-1 is an established substrate and 
transcription factor target for ERK signaling in MCF-7 
cells [29). Expression of constitutively active CaM KK in 
PC- I 2 cells has previously been shown to trigger tran-
scriptional activation through Elk- I by phosphorylation of 
serine 383 f 44]. The specific requirement for ERK in this 
activation was not examined. Consistent with these 
observations, we propose that carbachol operates through 
CaM KK, CaM KI, and ERK to stimulate Elk-I 
phosphorylation and transcription in MCF-7 cells. Inter-
estingly, carbachol and estrogen have also been suggested 
to increase Elk-1 phosphorylation and Egr-1 gene expres-
sion through ERK in SH-SYSY neuroblastoma cells and 
MCF-7 cells, respectively [6, 29, 75]. Egr-1 is an early 
growth ~esponse gene that encodes for a zinc finger tran-
scription factor and modulates transcription of several 
genes. We did not examine Egr-1 expression in MCF-7 
cells; however, this is an intriguing area for future studies 
in our model syste1n. CaM KT has also been proposed to 
regulate cjos gene expression and proliferation of osteo-
blasts [68). c-fos protein and genes are established targets 
of ERK in nu1.nerous cell types including fibroblasts and 
PC-12 cells f34, 76, 77]. It is interesting to speculate that 
perhaps ERK may also be operating dovvnstream of CaM 
KI to regulate c-fos gene expression. 
The various roles for CaM kinases in cellular function 
continue to generate exciting observations and the physi-
ological properties of CaM KK and CaM Kl is rapidly 
growing. Our observations expand our current under-
standing of CaM KK and CaM KI signaling to include their 
control of ERK, Elk-1 , and cyclin D 1 in breast cancer cells. 
We suggest a \Vorking model by which agonists that 
increase intracellular calciu1n concentration and CaM KK 
activation pro1note MCF-7 cell growth. Specifically, car-
bachol acting through the M3 muscarinic receptor tiiggers 
CaM KK, CaM KI, and ERK activation leading to the 
phosphorylation and activation of Elk- 1 and increases in 
cyclin DI expression. The physiological ligand, estrogen, 
also appears to utilize a sin1ilar intracellular signaling 
pathway in MCF-7 cells. Dissecting the signaling pathways 
utilized by calcium in cancer cells 1nay provide relevant 
targets for future studies in cancer biology. 
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